# Amplatzer Amulet LAAO vs. NOAC

Study · id `cardio:ct-nct04226547` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04226547](<https://clinicaltrials.gov/study/NCT04226547>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04226547

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 2650 participants.

## Technical summary

Registry record NCT04226547. Randomized; single masking; primary purpose treatment. Start 2020-07-07 (actual); primary completion 2029-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2650 participants (planned count; ClinicalTrials.gov record NCT04226547, source copy `cardio:ctgov-nct04226547-2026-02-10`, retrieved 2026-10-26)
- Started: 2020-07-07 (actual) (ClinicalTrials.gov record NCT04226547, source copy `cardio:ctgov-nct04226547-2026-02-10`, retrieved 2026-10-26)
- Primary completion: 2029-01 (anticipated) (ClinicalTrials.gov record NCT04226547, source copy `cardio:ctgov-nct04226547-2026-02-10`, retrieved 2026-10-26)
- Completion: 2031-04 (anticipated) (ClinicalTrials.gov record NCT04226547, source copy `cardio:ctgov-nct04226547-2026-02-10`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; Czechia; Denmark; France; Germany; Hong Kong SAR China; Italy; Japan; Lithuania; Netherlands; Poland; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04226547, source copy `cardio:ctgov-nct04226547-2026-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04226547-2026-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Amplatzer Amulet LAAO vs. NOAC
- Acronym: CATALYST
- Condition: Atrial Fibrillation
- Condition: Stroke
- Condition: Bleeding
- Intervention (Device): Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)
- Intervention (Drug): Non-Vitamin K Oral Antagonists
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Left atrial appendage occlusion (`cardio:left-atrial-appendage-occlusion`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 6572d0c9912b76049398f9ec99157dc12475a88a59f00357fa0f396e21536f76
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
